Cost-utility analysis from a societal perspective

被引:33
|
作者
Johannesson, M
OConor, RM
机构
[1] Centre for Health Economics, Stockholm School of Economics, Box 6501
关键词
cost-utility analysis; quality-adjusted life years; economic evaluation; societal perspective;
D O I
10.1016/S0168-8510(96)00878-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In this paper, we outline how to use cost-utility analysis from a societal perspective and the arguments that could be made For using such a model for economic evaluation of health care. We show that to include all the costs in the analysis, a price per quality-adjusted life years (QALY) gained rather than a given budget should be used as the decision rule. Using cost-utility analysis this way is based on a willingness to pay per QALY gained that is constant and the same for everyone. To use a fixed price per QALY gained is consistent with societal utility maximization if aggregated QALYs are a measure of societal utility and if the mix of financing sources is the same for all health care programmes. If, furthermore, the price per QALY gained is set at the optimal level, cost-utility analysis will lead to a maximization of societal utility. To get more information on the willingness to pay per QALY gained so as to provide cost-utility analysis with a useful decision rule should be a research priority. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:241 / 253
页数:13
相关论文
共 50 条
  • [1] Cost-utility of cochlear implants a societal perspective analysis
    Barlev, A
    Hay, JW
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 259 - 259
  • [2] COST-UTILITY ANALYSIS OF ROFLUMILAST CREAM FOR PLAQUE PSORIASIS, INCLUDING INTERTRIGINOUS, FROM THE CANADIAN SOCIETAL PERSPECTIVE
    Garrison, K.
    Zhang, W.
    Jensen, I. S.
    Shah, A.
    Brown, S.
    Stephenson, B.
    Yim, C.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S109 - S109
  • [3] Five-year cost-utility analysis of acute renal replacement therapy: a societal perspective
    Laukkanen, Annika
    Emaus, Linda
    Pettila, Ville
    Kaukonen, Kirsi-Maija
    [J]. INTENSIVE CARE MEDICINE, 2013, 39 (03) : 406 - 413
  • [4] Five-year cost-utility analysis of acute renal replacement therapy: a societal perspective
    Annika Laukkanen
    Linda Emaus
    Ville Pettilä
    Kirsi-Maija Kaukonen
    [J]. Intensive Care Medicine, 2013, 39 : 406 - 413
  • [5] Cost-Utility Analysis of Hub-and-Spoke Telestroke Networks for the Management of Acute Ischemic Stroke from a Societal Perspective
    Demaerschalk, Bart
    Switzer, Jeffrey
    Xie, Jipan
    Fan, Liangyi
    Villa, Kathleen
    Wu, Eric
    [J]. NEUROLOGY, 2012, 78
  • [6] Cost-utility analysis of duloxetine in osteoarthritis: from Chinese healthcare perspective
    Sun, Xueshan
    Zhen, Xuemei
    Gu, Shuyan
    Liu, Kaijie
    Yang, Wenqianzi
    Dong, Hengjin
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024,
  • [7] PRIMARY CARE DEMENTIA CLINIC REDUCES SOCIETAL COST OF DEMENTIA: A COST-UTILITY ANALYSIS
    Teo, W. K.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A411 - A411
  • [8] Cost-utility analysis
    Brown, GC
    Brown, MM
    Sharma, S
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 625 - 626
  • [9] COST-UTILITY ANALYSIS
    NICHOLLS, A
    [J]. BRITISH MEDICAL JOURNAL, 1993, 307 (6913): : 1213 - 1213
  • [10] Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective
    Marcellusi, Andrea
    Viti, Raffaella
    Russo, Simone
    Andreoni, Massimo
    Antinori, Andrea
    Mennini, Francesco Saverio
    [J]. CLINICAL DRUG INVESTIGATION, 2016, 36 (05) : 377 - 387